93 related articles for article (PubMed ID: 28099741)
1. Abortion choices among women in Cambodia after introduction of a socially marketed medicated abortion product.
Sotheary K; Long D; Mundy G; Madan Y; Blumenthal PD
Int J Gynaecol Obstet; 2017 Feb; 136(2):205-209. PubMed ID: 28099741
[TBL] [Abstract][Full Text] [Related]
2. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
Petitet PH; Ith L; Cockroft M; Delvaux T
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
[TBL] [Abstract][Full Text] [Related]
3. Provision of harm-reduction services to limit unsafe abortion in Tanzania.
Kahabuka C; Pembe A; Meglioli A
Int J Gynaecol Obstet; 2017 Feb; 136(2):210-214. PubMed ID: 28099731
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of early induced medical abortion with mifepristone when beginning progestin-only contraception on the same day.
Douthwaite M; Candelas JA; Reichwein B; Eckhardt C; Ngo TD; Domínguez A
Int J Gynaecol Obstet; 2016 Jun; 133(3):329-33. PubMed ID: 26969144
[TBL] [Abstract][Full Text] [Related]
5. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
Tamang A; Tamang J
Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
[TBL] [Abstract][Full Text] [Related]
6. Choosing early pregnancy termination methods in Urban Mozambique.
Mitchell EM; Kwizera A; Usta M; Gebreselassie H
Soc Sci Med; 2010 Jul; 71(1):62-70. PubMed ID: 20452107
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
Jensen JT; Harvey SM; Beckman LJ
Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
[TBL] [Abstract][Full Text] [Related]
8. Unsafe abortion as a birth control method: maternal mortality risks among unmarried cambodian migrant women on the Thai-Cambodia border.
Hegde S; Hoban E; Nevill A
Asia Pac J Public Health; 2012 Nov; 24(6):989-1001. PubMed ID: 21551135
[TBL] [Abstract][Full Text] [Related]
9. Instituting medical abortion services: changes in outcome and acceptability related to provider experience.
Borgatta L; Burnhill M; Haskell S; Nichols M; Leonhardt K
J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):173-6. PubMed ID: 10846332
[TBL] [Abstract][Full Text] [Related]
10. Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicentre randomised trial.
Meirik O; My Huong NT; Piaggio G; Bergel E; von Hertzen H;
Lancet; 2012 May; 379(9828):1817-24. PubMed ID: 22405255
[TBL] [Abstract][Full Text] [Related]
11. Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghana.
Ganle JK; Busia NT; Maya E
Int J Gynaecol Obstet; 2019 Feb; 144(2):167-173. PubMed ID: 30451283
[TBL] [Abstract][Full Text] [Related]
12. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India.
Ganatra B; Manning V; Pallipamulla SP
Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487
[TBL] [Abstract][Full Text] [Related]
13. Medical abortion and manual vacuum aspiration for legal abortion protect women's health and reduce costs to the health system: findings from Colombia.
Rodriguez MI; Mendoza WS; Guerra-Palacio C; Guzman NA; Tolosa JE
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):125-33. PubMed ID: 25702076
[TBL] [Abstract][Full Text] [Related]
14. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion.
Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE
Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348
[TBL] [Abstract][Full Text] [Related]
15. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
[TBL] [Abstract][Full Text] [Related]
18. Replacement of dilation and curettage/evacuation by manual vacuum aspiration and medical abortion, and the introduction of postabortion contraception in Pakistan.
Zaidi S; Yasmin H; Hassan L; Khakwani M; Sami S; Abbas T
Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S40-4. PubMed ID: 24743026
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
[TBL] [Abstract][Full Text] [Related]
20. Cervical priming with misoprostol before manual vacuum aspiration versus electric vacuum aspiration for first-trimester surgical abortion.
Mittal S; Sehgal R; Aggarwal S; Aruna J; Bahadur A; Kumar G
Int J Gynaecol Obstet; 2011 Jan; 112(1):34-9. PubMed ID: 21112054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
